4//SEC Filing
Wright-Mitchell Jane 4
Accession 0001209191-21-052311
CIK 0001649094other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 6:02 PM ET
Size
8.7 KB
Accession
0001209191-21-052311
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Mitchell Jane Wright
General Counsel
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-08-16−2,500→ 187,468 totalExercise: $2.03Exp: 2029-03-20→ Common Stock (2,500 underlying) - Sale
Common Stock
2021-08-16$26.00/sh−2,500$65,000→ 3,125 total - Exercise/Conversion
Common Stock
2021-08-16$2.03/sh+2,500$5,075→ 5,625 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001614568
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 6:02 PM ET
- Size
- 8.7 KB